RECURRENT VULVOVAGINAL CANDIDIASIS
Clinical trials for RECURRENT VULVOVAGINAL CANDIDIASIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT VULVOVAGINAL CANDIDIASIS trials appear
Sign up with your email to follow new studies for RECURRENT VULVOVAGINAL CANDIDIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New yeast infection pill could stop repeat episodes
Disease control CompletedThis study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three infections in the past year. Over 400 participants took either the study drug or a placebo for 12 weeks after an initial treatment, and…
Matched conditions: RECURRENT VULVOVAGINAL CANDIDIASIS
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill may keep yeast infections away for good
Disease control CompletedThis study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three infections in the past year. Participants first received standard treatment for their current infection, then took either oteseconazole…
Matched conditions: RECURRENT VULVOVAGINAL CANDIDIASIS
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC